Evidence map›Paper›PMID 14570724›Full record

ArticleGut2003

Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency.

I R Korponay-Szabó, I Dahlbom, K Laurila, S Koskinen, N Woolley, J Partanen, J B Kovács, M Mäki, T Hansson

Registry-linked trialAbstract readEvaluation Study
In one paragraph

Article in Gut, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05186038 (Scrutiny Based in a Novel Test to Help the Early Detection of Celiac Disease.), which is not on this map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05186038 completednot on this mapstarted 2021, after this paper: background citation

Scrutiny Based in a Novel Test to Help the Early Detection of Celiac Disease.

TypeobservationalSponsorBiomedal S.L.Ran2021 to 2022Enrolled1,000ConditionsCeliac DiseaseArmsiVYCHECK GIP Urine, CeliacDetect
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Immunoglobulin a Deficiency in Coeliac Disease: A Scoping Review.United European gastroenterology journal · 2026
    Article
  5. Review
  6. Observational
  7. Observational
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Clinical manifestation for immunoglobulin A deficiency: a systematic review and meta-analysis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Review
  19. Celiac Disease Revisited.GE Portuguese journal of gastroenterology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

I R Korponay-SzabóDepartment of Gastroenterology-Nephrology, Heim Pál Children's Hospital, Budapest, Hungary. Ilma.Korponay-Szabo@uta.fi
I Dahlbom
K Laurila
S Koskinen
N Woolley
J Partanen
J B Kovács
M Mäki
T Hansson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIgA serum autoantibodies against tissue transglutaminase (tTG) have an established diagnostic value in coeliac disease, and high efficacy tests are widely available for their detection. However, serological evaluation of IgA deficient subjects is still difficult.

aimsTo evaluate the diagnostic potential of IgG class anti-tTG autoantibodies measured quantitatively using an enzyme linked immunosorbent assay (ELISA) compared with immunofluorescent detection of coeliac autoantibodies. PATIENTS: We tested serum samples from 325 IgA deficient subjects, including 78 patients with coeliac disease, 73 disease controls, and 174 blood donors.

methodsIgG antibodies against human recombinant tTG were measured with an ELISA. IgG antiendomysium antibodies (EMA) were assayed by indirect immunofluorescence on human jejunum and appendix sections.

resultsThe IgG anti-tTG ELISA had a sensitivity of 98.7% and a specificity of 98.6%, and the correlation with IgG EMA titres was high (r(s)=0.91). One coeliac patient, initially negative in all autoantibody tests, displayed both IgG anti-tTG antibodies and IgG EMA during later gluten exposure. IgG anti-tTG antibodies and EMA titres showed significant decreases (p<0.001) in treated patients. The frequency of IgG anti-tTG autoantibody positivity was 9.8% among IgA deficient blood donors and 11 of the 12 positive subjects with known HLA-DQ haplotypes carried DQ2 or DQ8 alleles.

conclusionsIgG anti-tTG and IgG EMA autoantibody tests are highly efficient in detecting coeliac disease in IgA deficient patients. The high prevalence of coeliac antibodies among symptom free IgA deficient blood donors who also carry coeliac-type HLA-DQ genes indicates that all IgA deficient persons should be evaluated for coeliac disease.

Indexed as

AutoantibodiesCeliac DiseaseChildChild, PreschoolDietEnzyme-Linked Immunosorbent AssayFluorescent Antibody Technique, IndirectGenotypeGlutensHLA-DQ AntigensHumansImmunoglobulin AImmunoglobulin GInfantTransglutaminasesAutoantibodiesGlutensHLA-DQ8 antigenHLA-DQ AntigensImmunoglobulin AImmunoglobulin GTransglutaminases

Identifiers

PMID14570724
PMCPMC1773847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.